|Bid||301.51 x 1100|
|Ask||312.00 x 1800|
|Day's Range||303.42 - 310.43|
|52 Week Range||228.81 - 325.54|
|Beta (5Y Monthly)||0.73|
|PE Ratio (TTM)||121.23|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Global CRO takes action to further modernize study operations, adopting the Veeva Vault Clinical Operations Suite for greater efficiency and speed.
Boehringer Ingelheim is standardizing on Veeva CRM Engage Meeting to drive more valued interactions between its global field organization and HCPs.
Veeva eConsent makes it easier for patients to understand and provide electronic informed consent.